Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Emerson

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Hepatology (Baltimore, Md.)|September 1, 1987
Diminished serum Gc (vitamin D-binding protein) levels and increased Gc:G-actin complexes in a hamster model of fulminant hepatic necrosisW M Lee, D L Emerson, W O Young, et al.
Journal of Periodontal Research|July 1, 1987
Qualitative and quantitative studies of Gc (vitamin D-binding protein) in normal subjects and patients with periodontal diseaseJ W Krayer, D L Emerson, P J Goldschmidt-Clermont, et al.
Biology of the Neonate|January 1, 1987
High levels of group-specific component (vitamin-D-binding protein) in the cerebrospinal fluid of infants aged less than 2 monthsL P Katikaneni, D L Emerson, P J Goldschmidt-Clermont, et al.
Clinical Immunology and Immunopathology|November 1, 1985
Altered configuration of Gc on the plasma membrane of transformed and malignant human B lymphocytesA E Nel, M Navailles, D L Emerson, et al.
Biochemistry|October 21, 1986
Group-specific component (vitamin D binding protein) prevents the interaction between G-actin and profilinP J Goldschmidt-Clermont, E L Van Alstyne, J R Day, et al.
Clinical & Experimental Metastasis|March 21, 1998
Inhibition of establishment of primary and micrometastatic tumors by a urokinase plasminogen activator receptor antagonistD M Ignar, J L Andrews, S M Witherspoon, et al.
Journal of Medicinal Chemistry|March 31, 1995
Synthesis, topoisomerase I inhibitory activity, and in vivo evaluation of 11-azacamptothecin analogsD E Uehling, S S Nanthakumar, D Croom, et al.
Journal of Medicinal Chemistry|February 3, 1995
Synthesis and antitumor activity of novel water soluble derivatives of camptothecin as specific inhibitors of topoisomerase IM J Luzzio, J M Besterman, D L Emerson, et al.
Gene|April 29, 1997
Production of a urokinase plasminogen activator-IgG fusion protein (uPA-IgG) in the baculovirus expression systemT A Kost, D M Ignar, W C Clay, et al.
Cancer Research|February 1, 1995
In vivo antitumor activity of two new seven-substituted water-soluble camptothecin analoguesD L Emerson, J M Besterman, H R Brown, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Hepatology (Baltimore, Md.)|September 1, 1987
Diminished serum Gc (vitamin D-binding protein) levels and increased Gc:G-actin complexes in a hamster model of fulminant hepatic necrosisW M Lee, D L Emerson, W O Young, et al.
Journal of Periodontal Research|July 1, 1987
Qualitative and quantitative studies of Gc (vitamin D-binding protein) in normal subjects and patients with periodontal diseaseJ W Krayer, D L Emerson, P J Goldschmidt-Clermont, et al.
Biology of the Neonate|January 1, 1987
High levels of group-specific component (vitamin-D-binding protein) in the cerebrospinal fluid of infants aged less than 2 monthsL P Katikaneni, D L Emerson, P J Goldschmidt-Clermont, et al.
Clinical Immunology and Immunopathology|November 1, 1985
Altered configuration of Gc on the plasma membrane of transformed and malignant human B lymphocytesA E Nel, M Navailles, D L Emerson, et al.
Biochemistry|October 21, 1986
Group-specific component (vitamin D binding protein) prevents the interaction between G-actin and profilinP J Goldschmidt-Clermont, E L Van Alstyne, J R Day, et al.
Clinical & Experimental Metastasis|March 21, 1998
Inhibition of establishment of primary and micrometastatic tumors by a urokinase plasminogen activator receptor antagonistD M Ignar, J L Andrews, S M Witherspoon, et al.
Journal of Medicinal Chemistry|March 31, 1995
Synthesis, topoisomerase I inhibitory activity, and in vivo evaluation of 11-azacamptothecin analogsD E Uehling, S S Nanthakumar, D Croom, et al.
Journal of Medicinal Chemistry|February 3, 1995
Synthesis and antitumor activity of novel water soluble derivatives of camptothecin as specific inhibitors of topoisomerase IM J Luzzio, J M Besterman, D L Emerson, et al.
Gene|April 29, 1997
Production of a urokinase plasminogen activator-IgG fusion protein (uPA-IgG) in the baculovirus expression systemT A Kost, D M Ignar, W C Clay, et al.
Cancer Research|February 1, 1995
In vivo antitumor activity of two new seven-substituted water-soluble camptothecin analoguesD L Emerson, J M Besterman, H R Brown, et al.
Pageof 4